LADENBURG THALMANN FINANCIAL SERVICES INC. - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C113. A total of 4 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2017$4,000
-20.0%
30,0000.0%0.00%–
Q3 2017$5,0000.0%30,0000.0%0.00%–
Q2 2017$5,000
-28.6%
30,0000.0%0.00%–
Q1 2017$7,000
+16.7%
30,0000.0%0.00%–
Q4 2016$6,000–30,000–0.00%–
 Download
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q1 2017
NameSharesValueWeighting ↓
Anson Funds Management LP 2,221,722$1,235,0000.83%
SABBY MANAGEMENT, LLC 2,100,797$273,0000.02%
LADENBURG THALMANN FINANCIAL SERVICES INC. 30,000$4,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2,216,855$288,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders